Retreatment for HIV facial lipoatrophy

Retreatment for HIV facial lipoatrophy - Retreatment for HIV facial lipoatrophy

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000029667

Enrollment

Registered

2017-10-23

Start date

2017-10-23

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV facial lipoatrophy

Interventions

dermal filler (hyaluronic acid) administeration

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: well controlled HIV infection

Exclusion criteria

Exclusion criteria: platelet count lower than 50000/mm3 pregnancy

Design outcomes

Primary

Measure	Time frame
quantitative and qualitative evaluation of the facial soft tissue at 48 weeks	—

Countries

Japan

Contacts

Public ContactKunihisa Tsukada

National Center for Global Health and Medicine AIDS Clinical Center

ktsukada@acc.ncgm.go.jp+81-3-3202-7181

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026